Trial · NCT02203760
Pazopanib Vs. Pazopanib Plus Gemcitabine
NCT02203760, Phase 2, Active not recruiting, North Eastern German Society of Gynaecological Oncology
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pazopanib Vs. Pazopanib Plus Gemcitabine. Trials, record NCT02203760. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02203760
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pazopanib Vs. Pazopanib Plus Gemcitabine
- NCT number
- NCT02203760
- Status
- Active not recruiting
- Phases
- Phase 2
- Enrollment
- 58 participants, actual
- Lead sponsor
- North Eastern German Society of Gynaecological Oncology
- Conditions
- Leiomyosarcoma or Carcinosarcoma
- Interventions
- Pazopanib plus Gemcitabine, Pazopanib
- First posted
- 2014-07-30
- Last updated
- 2024-11-15
- Other registries' IDs
- eudract:2012-003810-15
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Progression free survival assessed as rate of patients without progression Second malignancy or clinical progression - patients with unknown or missing PFS will be treated as non-responder | 6 months | |
| Secondary | Objective response rate (RECIST v1.1 criteria) | One year | Time to progression (TTP) of a patient being defined as the time in months from start of the first therapy cycle until PD is observed |
| Secondary | Objective response rate (RECIST v1.1 criteria) | One year | Overall survival (OS) calculated from the day of study enrolment until the day of death |
| Secondary | Objective response rate (RECIST v1.1 criteria) | one year | Progression-free survival (PFS) calculated from the day of study enrolment until the day of progression/death |
| Secondary | Safety - side effects | One year | Toxicity and tolerability |
| Secondary | Quality of life (EORTC QLQ-C30) | One year | Quality of life (EORTC QLQ-C30) |
| Secondary | Translational research program | One year | Translational research within a tumour bank |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02203760
GET https://conductscience.org/api/trials/v1/NCT02203760/registered